US › Healthcare

Incannex Healthcare Ltd ADR (IXHL)

US · Healthcare · Drug Manufacturers - Specialty & Generic

$3.59-5.53%

Last close · 2026-09-17

Latest quarter · ended 2026-03-31

Revenue

Net profit

$-3.9M

EPS

$-0.49

EPS estimate

$-0.84

EPS came in at -0.49 against a street estimate of -0.84 — a beat of 41.7%.

Key statistics

Market cap

$45.5M

Forward P/E

3.8

P/B

0.55

Book value

$5.50

EPS (TTM)

$-16.62

52-week high

$20.31

52-week low

$2.49

50-day MA

$3.27

200-day MA

$5.65

Beta

2.83

Analyst view

with an average price target of $18.13.

Shareholding

Insiders

12.34%

Institutions

3.81%

Largest institutional holders

Fund	Stake
Polar Asset Management Partners	5.22%
Ghisallo Capital Management LLC	1.36%
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	1.25%
Murchinson Ltd.	0.87%
Millennium Management LLC	0.80%
LPL Financial Corp	0.59%
AdvisorShares Investments, LLC	0.51%
UBS Group AG	0.34%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Incannex Healthcare Ltd ADR — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.